Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ogata, A
Right arrow Articles by Kishimoto, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ogata, A
Right arrow Articles by Kishimoto, T
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Inhibitory effect of all-trans retinoic acid on the growth of freshly isolated myeloma cells via interference with interleukin-6 signal transduction [see comments]

A Ogata, N Nishimoto, Y Shima, K Yoshizaki and T Kishimoto

Department of Medicine III, Osaka University Medical School, Japan.

We showed the dose-dependent growth inhibition by alltrans retinoic acid (ATRA) of myeloma cells freshly isolated from patients. ATRA downregulated the cell surface expression of interleukin-6 receptor (IL- 6R) and/or glycoprotein (gp) 130. The growth-inhibitory activity of ATRA was well correlated with that of anti-gp 130 antibody in every sample. Furthermore, ATRA inhibited the production of IL-6 from both myeloma cells and marrow stromal cells, and recombinant IL-6 (rIL-6) could partially recover the myeloma cell growth that had been inhibited by ATRA. These data suggest that ATRA may inhibit the proliferation of myeloma cells both by the downregulation of IL-6R and gp130 expression on myeloma cells and by the inhibition of IL-6 production from myeloma and stromal cells. Prednisolone (PSL) and interferon-gamma (IFN-gamma) also inhibited the myeloma growth, while their effects were different from those of ATRA on IL-6 R and gp130 expression, IL-6 production, and morphological change. The inhibitory effect of ATRA on myeloma cell proliferation was observed in 10 of 14 samples obtained from eight patients, which suggests that ATRA may be a potent new therapeutic agent for some myeloma patients.

Volume 84, Issue 9, pp. 3040-3046, 11/01/1994
Copyright © 1994 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
C. Tabata, R. Tabata, Y. Kadokawa, S. Hisamori, M. Takahashi, M. Mishima, T. Nakano, and H. Kubo
Thalidomide Prevents Bleomycin-Induced Pulmonary Fibrosis in Mice
J. Immunol., July 1, 2007; 179(1): 708 - 714.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. Tabata, Y. Kadokawa, R. Tabata, M. Takahashi, K. Okoshi, Y. Sakai, M. Mishima, and H. Kubo
All-trans-Retinoic Acid Prevents Radiation- or Bleomycin-induced Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., December 15, 2006; 174(12): 1352 - 1360.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
W. D. Shingleton, D. Jones, X. Xu, T. E. Cawston, and A. D. Rowan
Retinoic acid and oncostatin M combine to promote cartilage degradation via matrix metalloproteinase-13 expression in bovine but not human chondrocytes
Rheumatology, August 1, 2006; 45(8): 958 - 965.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. Tabata, H. Kubo, R. Tabata, M. Wada, K. Sakuma, M. Ichikawa, S. Fujita, T. Mio, and M. Mishima
All-trans retinoic acid modulates radiation-induced proliferation of lung fibroblasts via IL-6/IL-6R system
Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L597 - L606.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
W. G. Douglas, E. Tracy, D. Tan, J. Yu, W. L. Hicks Jr., N. R. Rigual, T. R. Loree, Y. Wang, and H. Baumann
Development of Head and Neck Squamous Cell Carcinoma Is Associated With Altered Cytokine Responsiveness
Mol. Cancer Res., October 1, 2004; 2(10): 585 - 593.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. Hjertner, H. Hjorth-Hansen, M. Borset, C. Seidel, A. Waage, and A. Sundan
Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells
Blood, January 15, 2001; 97(2): 516 - 522.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Masood, S. Nagpal, T. Zheng, J. Cai, A. Tulpule, D. L. Smith, and P. S. Gill
Kaposi sarcoma is a therapeutic target for vitamin D3 receptor agonist
Blood, November 1, 2000; 96(9): 3188 - 3194.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
J. Sammons, N. Ahmed, M.A. Khokher, and H.T. Hassan
Mechanisms Mediating the Inhibitory Effect of All-Trans Retinoic Acid on Primitive Hematopoietic Stem Cells in Human Long-Term Bone Marrow Culture
Stem Cells, May 1, 2000; 18(3): 214 - 219.
[Abstract] [Full Text]


Home page
BloodHome page
Y.-H. Chen, D. Lavelle, J. DeSimone, S. Uddin, L. C. Platanias, and M. Hankewych
Growth Inhibition of a Human Myeloma Cell Line by All-trans Retinoic Acid Is Not Mediated Through Downregulation of Interleukin-6 Receptors but Through Upregulation of p21WAF1
Blood, July 1, 1999; 94(1): 251 - 259.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Hallek, P. Leif Bergsagel, and K. C. Anderson
Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process
Blood, January 1, 1998; 91(1): 3 - 21.
[Full Text] [PDF]


Home page
BloodHome page
M. Urashima, G. Teoh, D. Chauhan, Y. Hoshi, A. Ogata, S. P. Treon, R. L. Schlossman, and K. C. Anderson
Interleukin-6 Overcomes p21WAF1 Upregulation and G1 Growth Arrest Induced by Dexamethasone and Interferon-gamma in Multiple Myeloma Cells
Blood, July 1, 1997; 90(1): 279 - 289.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. A. O'Brien and S. C. Manolagas
Isolation and Characterization of the Human gp130 Promoter. REGULATION BY STATS
J. Biol. Chem., June 6, 1997; 272(23): 15003 - 15010.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Elizondo, J. Corchero, E. Sterneck, and F. J. Gonzalez
Feedback Inhibition of the Retinaldehyde Dehydrogenase Gene ALDH1 by Retinoic Acid through Retinoic Acid Receptor alpha and CCAAT/Enhancer-binding Protein beta
J. Biol. Chem., December 8, 2000; 275(50): 39747 - 39753.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1994 by American Society of Hematology         Online ISSN: 1528-0020